April 7th, 2021In the first wave of COVID-19, the mortality rate in a London hospital was roughly the same as that from Ebola in West Africa in 2014, says Professor Peter Piot,...
April 7th, 2021In response to US government concerns over data used, AstraZeneca released updated information on its COVID-19 clinical trial, showing an effectiveness rate of 76%...
Researchers reporting on two non-peer–reviewed studies followed up months after adults' COVID-19 hospitalisation and found that 55% to 71% have not fully recovered....Coronavirus Watch
A new systematic review of 65 studies from around the world involves a total of 97,333 health care workers and finds that 1 in 5 have experienced depression, anxiety,...Weekly Roundup
Evidence continues to mount that the so-called UK variant is "likely" deadlier and results in more hospitalisations than non-variant COVID-19 cases, according to data...Coronavirus
Research led by Professor Julia Hippisley-Cox in the University of Oxford’s Nuffield department of primary care health sciences, with collaborators across the UK,...
February 17th, 2021Patients given prophylactic anticoagulants within 24 hours of admission to hospital with COVID-19 was associated with a decreased risk of 30 day mortality and no...
The an anti-inflammatory treatment, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19, shows the RECOVERY trial, writes...
January 13th, 2021‘Long COVID’ – a version of COVID-19 that results in continued illness of a significant number of people for many months after the initial disease has waned –...
Pfizer Inc and BioNTech SE have announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies...
